Abstract
Justification
Children with cancer need to be immunized against the common vaccine-preventable diseases after completion and sometimes during ongoing treatment of cancer. However, the immunization schedule for these children needs to be altered due to disease and treatment related immune-suppression. Consequently, there are many guidelines/practice statements from around the world to address this issue, however, there is no such comprehensive guideline from India catering to the need of Indian children with cancer.
Process
A guideline was drafted after reviewing the available literature. The draft guideline was discussed and modified in a meeting attended by pediatric oncologists from the PHO chapter and vaccine experts from the ACVIP of the IAP. Subsequently, the modified draft was reviewed and recommendations were finalized.
Objective
To review the current evidence and generate a nationally relevant guideline for immunization of children receiving chemotherapy for cancer.
Recommendations
Live vaccines are contraindicated during and up to 6 months after end of chemotherapy. Non-live vaccines are also best given after 6 months from the end of treatment for durable immunity. Annual inactivated influenza vaccine is the only vaccine recommended for all children during chemotherapy whereas hepatitis B vaccine is recommended only for previously unimmunised children with risk of transfusion associated transmission of infection. Post-treatment re-immunization/catch-up schedule largely depends on the pre-chemotherapy immunization status. Sibling immunization should continue uninterrupted except for oral polio vaccine which needs to be substituted by the injectable vaccine. Inactivated influenza vaccine is recommended and varicella vaccine is encouraged for all contacts including siblings.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Craft AW. Childhood cancer — mainly curable so where next? Acta Paediatr. 2000;89:386–92.
Arora RS, Prabha S, Moulik NR, Bagai P. A survey of immunization practices in children with cancer in India. Pediatr Hematol Oncol J. 2016;1:2–5.
Chowdhury P, Vashishtha VM. Immunization in special situations: In: IAP Guidebook on immunization [2013-14] — By Advisory Committee on Vaccines and Immunization Practices [ACVIP], Indian Academy of Pediatrics. National Publishing House, Indian Academy of Pediatrics, Gwalior. 2014;365–84.
Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:309–18.
Royal College of Paediatrics and Child Health [RCPCH]. Immunization of the immunocompromised child—Best practice statement. United Kingdom: RCPCH; 2002:10–3.
Patel SR, Chisholm JC, Heath PT. Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation. Pediatr Clin North Am. 2008;55:169–86.
Patel SR, Ortín M, Cohen BJ, Borrow R, Irving D, Sheldon J, et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis. 2007;44:635–42.
Cesaro S, Giacchino M, Fioredda F, Barone A, Battisti L, Bezzio S, et al. Guidelines on vaccinations in paediatric haematology and oncology patients. Biomed Res Int. 2014;2014:707691.
Allen UD. Immunizations for children with cancer. Pediatr Blood Cancer. 2007;49:1102–8.
The Australian Immunization handbook, 10th Edition. 2013: 148–57. Available from: http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/7B28E87511E08905CA257D4D001DB1F8/$File/Aus-Imm-Handbook.pdf. Accessed June 10, 2019
Naqvi A, Fadoo Z, Alvi S. Vaccination guidelines for children with cancer and hematopoietic stem cell transplantation living in resource-poor countries. Pediatr Blood Cancer. 2010;54:3–7.
Balasubramanian S, Shah A, Pemde HK, Chatterjee P, Shivananda S, Guduru VK, Soans S, Shastri D, Kumar R; IAP Advisory Committee on Vaccines and Immunization Practices, 2018–19. Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP) Recommended Immunization Schedule (2018–19) and Update on Immunization for Children Aged 0 Through 18 Years. Indian Pediatr. 2018;55:1066–74.
Martín Ibáñez I, Arce Casas A, Cruz Martínez O, Estella Aguado J, Martín Mateos MA. Humoral immunity in pediatric patients with acute lymphoblastic leukaemia. Allergol Immunopathol (Madr). 2003;31:303–10.
Hersh EM, Whitecar JP, McCredie KB, Bodey GP Sr, Freireich EJ. Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N Engl J Med. 1971;285:1211–16.
Fuks Z, Strober S, Bobrove AM, Sasazuki T, McMichael A, Kaplan HS. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin’s disease. J Clin Invest. 1976;58:803–14.
Magrath IT, Simon RM. Immunosuppression in Burkitt’s lymphoma. II. Peripheral blood lymphocyte populations related to clinical status. Int J Cancer. 1976;18:399–408.
Shetty AK, Winter MA. Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation. Ochsner J. 2012;12:228–43.
Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: A review. Oncologist. 1999;4:370–8.
Nilsson A, De Milito A, Engström P, Nordin M, Narita M, Grillner L, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics. 2002;109:e91.
Leung W, Neale G, Behm F, Iyengar R, Finkelstein D, Kastan MB, Pui CH. Deficient innate immunity, thymopoiesis, and gene expression response to radiation in survivors of childhood acute lymphoblastic leukemia. Cancer Epidemiol. 2010;34:303–8.
Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D’Elia R. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2004;101:635–41.
Stenvik M, Hovi L, Siimes MA, Roivainen M, Hovi T. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign. Pediatr Infect Dis J. 1987;6:1106–10.
Katewa S, Sachdeva A. Vaccination in immuno-compromised children. In: IAP Textbook of Vaccines, 1st Edition, New Delhi Jaypee Brothers, New Delhi, 2014:507–15.
Ghosh N, Mannan MA, Monjur F, Rizwan F, Salim AF. Escalated regimen of hepatitis B vaccine in childhood hematological malignancies while on chemotherapy. Southeast Asian J Trop Med Public Health. 2010;41:555–61.
Indian Academy of Pediatrics Committee on Immunization [IAPCOI]. Consensus recommendations on immunization and IAP immunization timetable 2012. Indian Pediatr. 2012;49:549–64.
Verma R, Khanna P. Hepatitis A vaccine should receive priority in National Immunization Schedule in India. Hum Vaccin Immunother. 2012;8:1132–4.
Palefsky JM, Gillison ML, Strickler HD. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine. 2006;24:S3/140-6.
Succi RC, Farhat CK. Vaccination in special situations. J Pediatr [Rio J] 2006;82:S91–100.
Zengin E, Sarper N. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination. Pediatr Blood Cancer. 2009;53:967–72.
Lee PI, Chen PY, Huang YC, Lee CY, Lu CY, Chang MH, et al. Recommendations for rotavirus vaccine. Pediatr Neonatol. 2013;54:355–9.
Mavinkurve-Groothuis AM, van der Flier M, Stelma F, van Leer-Buter C, Preijers FW, Hoogerbrugge PM. Absolute lymphocyte count predicts the response to new influenza virus H1N1 vaccination in pediatric cancer patients. Clin Vaccine Immunol. 2013;20:118–21.
Sung L, Heurter H, Zokvic KM, Ford-Jones EL, Weitzman SS, Freeman R, et al. Practical vaccination guidelines for children with cancer. Paediatr Child Health. 2001;6:379–83.
Shahin K, Lina B, Billaud G, Pedone C, Faure-Conter C. Successful H1N1 influenza vaccination of children receiving chemotherapy for solid tumors. J Pediatr Hematol Oncol. 2012;34:e228–31.
Bate J, Chisholm J, Heath PT, Breuer J, Skinner R, Manley S et al. PEPtalk: postexposure prophylaxis against varicella in children with cancer. Arch Dis Child. 2011;96:841–5.
Shahmahmoodi S, Mamishi S, Aghamohammadi A, Aghazadeh N, Tabatabaie H, Gooya MM, et al. Vaccine-associated paralytic poliomyelitis in immunodeficient.
Funding
Funding: None
Author information
Authors and Affiliations
Contributions
Contributors: RSA, NRM: conceptualised the guideline. NRM, JC, PM, RSA: a draft guideline was produced. The guideline was discussed in a meeting by nominated representatives of the PHO chapter (NS, SB) and the ACVIP (PJ, SS) of the IAP; NRM, RSA: following the meeting the guideline was modified and circulated amongst the authors (NRM, RSA, PM, JC, NS, SB, PJ and SS); NRM,RSA: The final modifications were made. All the authors approved the final manuscript.
Corresponding author
Ethics declarations
Competing Interests: None stated.
Rights and permissions
About this article
Cite this article
Moulik, N.R., Mandal, P., Chandra, J. et al. Immunization of Children with Cancer in India Treated with Chemotherapy — Consensus Guideline from the Pediatric Hematology-Oncology Chapter and the Advisory Committee on Vaccination and Immunization Practices of the Indian Academy of Pediatrics. Indian Pediatr 56, 1041–1048 (2019). https://doi.org/10.1007/s13312-019-1678-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-019-1678-0